Q3 2025 13F Holders as of 30 Sep 2025
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
29,787,647
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
5,609,415
-
Shares change
-
-1,256,651
-
Total reported value, excl. options
-
$7,909,282
-
Value change
-
-$2,933,647
-
Number of buys
-
9
-
Number of sells
-
7
-
Price
-
$1.41
Institutional Holders of Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) as of Q3 2025
As of 30 Sep 2025 Senti Biosciences, Inc. - Common Stock, par value $0.0001 per share (SNTI) had 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 5,609,415 shares of stock of the company.
Largest 10 holders included NEA Management Company, LLC, Nantahala Capital Management, LLC, VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC, CITADEL ADVISORS LLC, XTX Topco Ltd, BlackRock, Inc., NORTHERN TRUST CORP, TWO SIGMA INVESTMENTS, LP, and STATE STREET CORP.
This table shows 15 institutional shareholders of the security as of 30 Sep 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.